Clinical outcomes in patients with faster advancing MS treated with teriflunomide in TEMSO and TOWER

被引：0
|
作者：
Kappos, L. [1 ]
Thangavelu, K. [2 ]
Cavalier, S. [2 ]
Truffinet, P. [3 ]
Comi, G. [4 ]
Miller, A. [5 ]
机构：
[1] Univ Hosp Basel, Basel, Switzerland
[2] Sanofi Genzyme, Cambridge, MA USA
[3] Sanofi Genzyme, Chilly Mazarin, France
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P11185
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [31] Clinical and Safety Outcomes From Patients Treated With Teriflunomide in the Phase 4 Teri-PRO Study
    Gold, Ralf
    Khatri, Bhupendra
    Edwards, Keith R.
    Lallana, Jose Meca
    Cavalier, Steve
    Rufi, Pascal
    Benamor, Myriam
    Brette, Sandrine
    Chowdhury, Somankumar
    Coyle, Patricia K.
    NEUROLOGY, 2017, 88
  • [32] Long-Term Outcomes in Patients With Progressive Forms of Relapsing MS Treated With Teriflunomide: Real-World Evidence
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Boyko, Alexey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Berkovich, Regina
    NEUROLOGY, 2018, 90
  • [33] Long-Term Outcomes in Patients with Progressive Forms of Relapsing MS Treated with Teriflunomide: Real-World Evidence
    Berkovich, Regina
    Thangavelu, Karthinathan
    Cavalier, Steven J.
    Truffinet, Philippe
    Nelson, Flavia
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 20 - 20
  • [34] The efficacy and safety of teriflunomide in patients with relapsing MS: results from TOWER, a phase III, placebocontrolled study
    Kappos, L.
    Comi, G.
    Confavreux, C.
    Freedman, M. S.
    Miller, A. E.
    Olsson, T. P.
    Wolinsky, J. S.
    Bagulho, T.
    Delhay, J. -L.
    Zheng, Y.
    Truffinet, P.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 50 - 51
  • [35] Cases of COVID-19 in Teriflunomide-Treated Patients With MS: Pharmacovigilance Report
    Louapre, Celine
    Garcia-Dominguez, Jose Manuel
    Moiola, Lucia
    Filippi, Massimo
    Tornatore, Carlo
    van Wingerden, Janneke
    Benamor, Myriam
    NEUROLOGY, 2021, 96 (15)
  • [36] Outcomes in Patients with Progressive MS: Analysis of Teriflunomide Long-Term Extension Data
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Camu, William
    Boyko, Alexey
    Thangavelu, Karthinathan
    Rufi, Pascal
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Lublin, Fred
    NEUROLOGY, 2016, 86
  • [37] Efficacy and safety of teriflunomide in Chinese patients with relapsing forms of MS: A subgroup analysis of the phase 3 tower study
    Macdonell, R.
    Freedman, M.
    Xu, X.
    Vucic, S.
    Truffinet, P.
    Benamor, M.
    Thangavelu, K.
    Miller, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 135 - 135
  • [38] Comparative analysis of MS outcomes in dimethyl fumarate-treated patients relative to propensity matched fingolimod, interferon, glatiramer acetate, or teriflunomide
    Spelman, T.
    Kalincik, T.
    Trojano, M.
    Grand'Maison, F.
    Izquierdo, G.
    Havrdova, E.
    Horakova, D.
    Lugaresi, A.
    Duquette, P.
    Grammond, P.
    Hupperts, R.
    Lechner-Scott, J.
    Granella, F.
    Petersen, T.
    Terzi, M.
    Pucci, E.
    Sola, P.
    Van Pesch, V.
    Iuliano, G.
    Oreja-Guevara, C.
    Boz, C.
    Bergamaschi, R.
    Slee, M.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 602 - 603
  • [39] Comparative analysis of MS outcomes in dimethyl fumarate-treated patients relative to propensity matched fingolimod, interferon, glatiramer acetate, or teriflunomide
    Spelman, Timothy
    Kalincik, Tomas
    Trojana, Maria
    Grand-Maison, Francois
    Izquierdo, Guillermo
    Havrdova, Eva
    Horakova, Dana
    Lugaresi, Alessandra
    Duquette, Pierre
    Grammond, Pierre
    Hupperts, Raymond
    Lechner-Scott, Jeannette
    Granella, Franco
    Petersen, Thor
    Terzi, Murat
    Pucci, Eugenio
    Sola, Patrizia
    Van Pesch, Vincent
    Luliano, Gerardo
    Boz, Cavit
    Bergamaschi, Roberto
    Slee, Mark
    Butzkueven, Helmut
    NEUROLOGY, 2017, 88
  • [40] Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide
    Henson, Lily J.
    Afsar, Salman
    Davenport, Lynn
    Purvis, Annie
    Poole, Elizabeth M.
    Truffinet, Philippe
    REPRODUCTIVE TOXICOLOGY, 2020, 95 : 45 - 50
12345